Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × tetrathiomolybdate × Clear all

NCT00150995 2015-01-21

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00405574 2008-01-30

Study of ATN-224 in Patients With Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms